These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20696896)

  • 21. C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity.
    Sauer M; Bretz AC; Beinoraviciute-Kellner R; Beitzinger M; Burek C; Rosenwald A; Harms GS; Stiewe T
    Nucleic Acids Res; 2008 Apr; 36(6):1900-12. PubMed ID: 18267967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
    Robinson RA; Lu X; Jones EY; Siebold C
    Structure; 2008 Feb; 16(2):259-68. PubMed ID: 18275817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 Family isoforms.
    Bourdon JC
    Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.
    Xu J; Reumers J; Couceiro JR; De Smet F; Gallardo R; Rudyak S; Cornelis A; Rozenski J; Zwolinska A; Marine JC; Lambrechts D; Suh YA; Rousseau F; Schymkowitz J
    Nat Chem Biol; 2011 May; 7(5):285-95. PubMed ID: 21445056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
    Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
    Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the transactivation domains of p53 family members: a computational study.
    Mavinahalli JN; Madhumalar A; Beuerman RW; Lane DP; Verma C
    BMC Genomics; 2010 Feb; 11 Suppl 1(Suppl 1):S5. PubMed ID: 20158876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulating the genome surveillance system: miRNAs and the p53 super family.
    Bailey SG; Sanchez-Elsner T; Stephanou A; Cragg MS; Townsend PA
    Apoptosis; 2010 May; 15(5):541-52. PubMed ID: 20091234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.
    Ethayathulla AS; Nguyen HT; Viadiu H
    J Biol Chem; 2013 Feb; 288(7):4744-54. PubMed ID: 23243311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for ASPP2 recognition by the tumor suppressor p73.
    Canning P; von Delft F; Bullock AN
    J Mol Biol; 2012 Nov; 423(4):515-27. PubMed ID: 22917970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure, function and regulation of p63 and p73.
    Levrero M; De Laurenzi V; Costanzo A; Gong J; Melino G; Wang JY
    Cell Death Differ; 1999 Dec; 6(12):1146-53. PubMed ID: 10637429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?
    Zawacka-Pankau J; Kostecka A; Sznarkowska A; Hedström E; Kawiak A
    Cell Cycle; 2010 Feb; 9(4):720-8. PubMed ID: 20160513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.
    Johnson RA; Shepard EM; Scotto KW
    J Biol Chem; 2005 Apr; 280(14):13213-9. PubMed ID: 15634666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 Family members p63 and p73 are SAM domain-containing proteins.
    Thanos CD; Bowie JU
    Protein Sci; 1999 Aug; 8(8):1708-10. PubMed ID: 10452616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P63 in health and cancer.
    Gonfloni S; Caputo V; Iannizzotto V
    Int J Dev Biol; 2015; 59(1-3):87-93. PubMed ID: 26374530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
    Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 protein variants: structural and functional similarities with p63 and p73 isoforms.
    Courtois S; Caron de Fromentel C; Hainaut P
    Oncogene; 2004 Jan; 23(3):631-8. PubMed ID: 14737098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and function in the p53 family.
    Arrowsmith CH
    Cell Death Differ; 1999 Dec; 6(12):1169-73. PubMed ID: 10637432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High thermostability and lack of cooperative DNA binding distinguish the p63 core domain from the homologous tumor suppressor p53.
    Klein C; Georges G; Künkele KP; Huber R; Engh RA; Hansen S
    J Biol Chem; 2001 Oct; 276(40):37390-401. PubMed ID: 11477076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.